Preferred Label : dihydroergotamine;
MeSH definition : A 9,10alpha-dihydro derivative of ERGOTAMINE. It is used as a vasoconstrictor, specifically
for the therapy of MIGRAINE DISORDERS.;
CISMeF synonym : 6190-39-2 (Dihydroergotamine mesylate); pharmafrid brand of dihydroergotamine mesylate; shire brand of dihydroergotamine mesylate; xcel brand 2 of dihydroergotamine mesylate; alpharma brand of dihydroergotamine mesylate; ratiopharm brand of dihydroergotamine mesylate; aliud brand of dihydroergotamine mesylate; wernigeroide brand of dihydroergotamine mesylate; Q-Pharm brand of dihydroergotamine mesylate; Q pharm brand of dihydroergotamine mesylate; anto brand of dihydroergotamine mesylate; fujisawa brand of dihydroergotamine mesylate; desitin brand of dihydroergotamine mesylate; ct-Arzneimittel brand of dihydroergotamine mesylate; ct arzneimittel brand of dihydroergotamine mesylate; pierre fabre brand of dihydroergotamine mesylate; xcel brand 1 of dihydroergotamine mesylate; novartis brand of dihydroergotamine mesylate; sanol brand of dihydroergotamine mesylate; schwarz brand of dihydroergotamine mesylate; IPRAD brand of dihydroergotamine mesylate; verla brand of dihydroergotamine mesylate; farmasan brand of dihydroergotamine mesylate; hormosan brand of dihydroergotamine mesylate;
MeSH hyponym : D-Tamin retard L.U.T.; DHE-Puren; dihydroergotamin AL; DET MS; migranal; DHE-ratiopharm; DHE-45; ergotam von ct; verladyn; ergomimet; ergont; seglor; tamik; clavigrenin; dihytamin; erganton; ikaran; orstanorm; angionorm; Dihydroergotamine Mesylate; D Tamin Retard L.U.T.; DHE 45; DHE45; D.H.E. 45; DHE Puren; DHE Ratiopharm; Mesylate, Dihydroergotamine; Dihydroergotamine Methanesulfonate; Methanesulfonate, Dihydroergotamine; Von Ct, Ergotam; Dihydergot; Dihydroergotamine-Sandoz; Dihydroergotamine Sandoz; Agit;
MeSH CAS label : Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-,
(5'alpha,10alpha)-;
MeSH Related Number : dihydroergotamine mesylate; 511-12-6 (Dihydroergotamine); 6190-39-2 (mesylate); 81AXN7R2QT;
Registry Number MeSH : 511-12-6;
Related CAS MeSH : 81AXN7R2QT (Dihydroergotamine mesylate);
Wikipedia link : https://en.wikipedia.org/wiki/Dihydroergotamine;
Codes EINECS : 208-123-3;
Is substance : O;
UNII : 436O5HM03C;
InChIKey : LUZRJRNZXALNLM-JGRZULCMSA-N;
Origin ID : D004087;
UMLS CUI : C0012291;
ATC code(s)
ATC code(s)
Allowable qualifiers
Automatic exact mappings (from CISMeF team)
Currated CISMeF NLP mapping
False automatic mappings
- agitation [Blood Transfusion thesaurus concept]
- agitator [Blood Transfusion thesaurus concept]
Pharmacological action(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
- DHE 45 [ICD-11 Extension code]
A 9,10alpha-dihydro derivative of ERGOTAMINE. It is used as a vasoconstrictor, specifically
for the therapy of MIGRAINE DISORDERS.
http://www.has-sante.fr/portail/jcms/c_2041958/fr/diergospray-dihydroergotamine-amdipharm
2015
false
false
false
France
French
evaluation of the transparency committee
dihydroergotamine
dihydroergotamine
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62058327
2012
France
summary of product characteristics
package leaflet
dihydroergotamine
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=69554906
2012
France
summary of product characteristics
package leaflet
dihydroergotamine
tablets
---
http://www.has-sante.fr/portail/jcms/c_1294640/dihydroergotamine-amdipharm-ikaran-lp-seglor-seglor-lyoc-tamik-dihydroergotamine-et-desernil-methysergide-derives-ergotes
http://www.has-sante.fr/portail/jcms/c_1294612/dhe-migraine-synthese-23052012
http://www.has-sante.fr/portail/jcms/c_1257411/dhe-amdipharm-23052012-avis-ct12061
http://www.has-sante.fr/portail/jcms/c_1257431/ikaran-23052012-avis-ct12075-11038
http://www.has-sante.fr/portail/jcms/c_1257339/seglor-23052012-avis-ct11066-12147
http://www.has-sante.fr/portail/jcms/c_1257452/tamik-23052012-avis-ct12044
http://www.has-sante.fr/portail/jcms/c_1257408/desernil-23052012-avis-ct12062-11053
2012
France
French
antimigraine preparations
migraine disorders
treatment outcome
insurance, health, reimbursement
administration, oral
methysergide
methysergide
Methysergide Maleate
injections
dihydroergotamine
Dihydroergotamine Mesylate
dihydroergotamine
Delayed-Action preparations
dihydroergotamine
Dihydroergotamine Mesylate
methysergide
Methysergide Maleate
guidelines for drug use
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/jcms/c_1256030/seglor
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-06/seglor_23052012_avis_ct11066_12147.pdf
2012
France
French
evaluation of the transparency committee
antimigraine preparations
dihydroergotamine
administration, oral
treatment outcome
insurance, health, reimbursement
dihydroergotamine
Dihydroergotamine Mesylate
Dihydroergotamine Mesylate
analgesics, non-narcotic
analgesics, non-narcotic
migraine disorders
vasoconstrictor agents
vasoconstrictor agents
randomized controlled trials as topic
fibrosis
risk assessment
product surveillance, postmarketing
dihydroergotamine
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-06/dhe_amdipharm_23052012_avis_ct12061.pdf
http://www.has-sante.fr/portail/jcms/c_1256037/dihydroergotamine-amdipharm
2012
France
French
evaluation of the transparency committee
antimigraine preparations
dihydroergotamine
dihydroergotamine
administration, oral
injections
insurance, health, reimbursement
treatment outcome
Dihydroergotamine Mesylate
Dihydroergotamine Mesylate
dihydroergotamine
analgesics, non-narcotic
analgesics, non-narcotic
vasoconstrictor agents
vasoconstrictor agents
migraine disorders
randomized controlled trials as topic
fibrosis
risk assessment
product surveillance, postmarketing
---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63221752
2012
France
summary of product characteristics
package leaflet
dihydroergotamine
injections
---
http://www.has-sante.fr/portail/display.jsp?id=c_574629
http://www.has-sante.fr/portail/jcms/c_1256031/tamik
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-06/tamik_230520128avis_ct12044.pdf
2012
France
French
antimigraine preparations
administration, oral
capsules
analgesics, non-narcotic
dihydroergotamine
vasoconstrictor agents
migraine disorders
dihydroergotamine
treatment outcome
Dihydroergotamine Mesylate
randomized controlled trials as topic
fibrosis
risk assessment
product surveillance, postmarketing
dihydroergotamine
Dihydroergotamine Mesylate
vasoconstrictor agents
analgesics, non-narcotic
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-06/ikaran_23052012_avis_ct12075_11038.pdf
http://www.has-sante.fr/portail/jcms/c_574461/ikaran
http://www.has-sante.fr/portail/jcms/c_1256023/ikaran
2012
France
French
evaluation of the transparency committee
antimigraine preparations
dihydroergotamine
Dihydroergotamine Mesylate
Dihydroergotamine Mesylate
dihydroergotamine
dihydroergotamine
administration, oral
insurance, health, reimbursement
treatment outcome
migraine disorders
analgesics, non-narcotic
analgesics, non-narcotic
randomized controlled trials as topic
vasoconstrictor agents
vasoconstrictor agents
risk assessment
fibrosis
product surveillance, postmarketing
---
http://www.lecrat.eu/?s=Dihydroergotamine
2009
France
French
pregnancy
dihydroergotamine
vasoconstrictor agents
analgesics, non-narcotic
dihydroergotamine
Dihydroergotamine Mesylate
drug information
---
http://www.has-sante.fr/portail/display.jsp?id=c_538327
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct-3954_seglor_.pdf
2007
France
French
antimigraine preparations
analgesics, non-narcotic
administration, oral
dihydroergotamine
vasoconstrictor agents
migraine disorders
hypotension, orthostatic
dihydroergotamine
insurance, health, reimbursement
Dihydroergotamine Mesylate
evaluation of the transparency committee
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/ct-3027_ikaran_.pdf
http://www.has-sante.fr/portail/display.jsp?id=c_493289
2007
France
French
antimigraine preparations
pharmaceutical solutions
tablets
dihydroergotamine
vasoconstrictor agents
migraine disorders
analgesics, non-narcotic
hypotension, orthostatic
dihydroergotamine
venous insufficiency
insurance, health, reimbursement
Delayed-Action preparations
Dihydroergotamine Mesylate
evaluation of the transparency committee
---